Steroid responsive nucleic acid expression and prediction of disease activity

Details for Australian Patent Application No. 2007309726 (hide)

Owner XDX, Inc.

Inventors Klingler, Tod M.; Lal, Preeti; Rosenberg, Steven

Agent Spruson & Ferguson

Pub. Number AU-A-2007309726

PCT Pub. Number WO2008/051290

Priority 60/790,474 07.04.06 US

Filing date 9 April 2007

Wipo publication date 2 May 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2008/051290 Priority application(s): WO2008/051290

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309727-Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

2007309718-Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin -1-yl)thieno(2,3-d)pyrimidine